Fig. 8.
Investigating the synergistic effects of vaccination Adh5T4/DCh5T4 versus DCh5T4/Adh5T4 with in-vivo depletion of CD25+ lymphocytes in mice with pre-existing tumours. Depletion of CD25+ cells does not alter survival when combined with Adh5T4/DCh5T4 (a), but dramatically improves the efficacy of DCh5T4/Adh5T4 vaccinations (b)